At a glance
ClinicalIndex Comparison Record- ✓Visually significant cataracts present
- ✓Pre-operative visual acuity 20/50 or worse
- ✓Pre-operative OCT showing at least 250 microns central foveal thickness
- ✕Macular ischemia
- ✕Vitreomacular traction
- ✕Macular hole
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Role of Triamcinolone Injection During Cataract Extraction for Diabetic Patients With Pre-Operative Macular Edema
In Brief
A clinical study evaluating Triamcinolone acetonide and laser for DIABETIC MACULAR EDEMA. Completed, enrolled 11 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if intravitreal triamcinolone acetonide (IVTA) injection at the time of cataract surgery will improve visual acuity and decrease post-operative swelling in diabetic patients requiring cataract extraction as compared to the conventional treatment of laser following cataract surgery. The subjects will be followed for 11 visits over 3 year. Visits will occur at screening,1, 3,6,9,12,18,24,30 and 36 months post surgery.
Study Details
Timeline
Interventions
4mg of intravitreal triamcinolone at time of cataract surgery with option to repeat at one month if no response
Laser treatment 1 month after cataract surgery with option to repeat once if no improvement.